ARTG 346690Geenius HCV Supplemental Assay - Hepatitis C virus total antibody IVD, kit, immunochromatographic test (ICT), rapid
ARTG ID: 346690 · Bio-Rad Laboratories Pty Ltd · Bio-Rad · Class III · Started October 28, 2020
Good Name: Bio-Rad Laboratories Pty Ltd - Geenius HCV Supplemental Assay - Hepatitis C virus total antibody IVD, kit, immunochromatographic test (ICT), rapid
- Risk Class
- Class III
- Product Type
- IVD
- ARTG Category
- IVD
- ARTG ID
- 346690
- Start Date
- October 28, 2020
- Effective Date
- October 28, 2020
- Name
- Bio-Rad
- Country
- France
- Address
- 3 Boulevard Raymond Poincare, 92430 MARNES-LA-COQUETTE
For the confirmation of the presence of antibodies associated with infection caused by Hepatitis C Virus (HCV) in human venous whole blood, serum or plasma specimen from individuals (including blood donors) or patients.
Access comprehensive regulatory information for Geenius HCV Supplemental Assay - Hepatitis C virus total antibody IVD, kit, immunochromatographic test (ICT), rapid in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 346690 and sponsored by Bio-Rad Laboratories Pty Ltd, manufactured by Bio-Rad in France. The device registration started on October 28, 2020.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.